Beneficial effects of pravastatin in peri- and postmenopausal hyperlipidemic women: A 5-year study on serum lipid and sex hormone levels

Maturitas

Volumn 37, Issue 3, 2001, Pages 201-208

  Ushiroyama, Takahisa ^a   Ikeda, Atsushi ^a   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Endocrine change; Hyperlipidemia; Long term effects; Menopause; Pravastatin

Indexed keywords

PRAVASTATIN; SEX HORMONE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROTEIN MODIFICATION; RISK BENEFIT ANALYSIS; SMOOTH MUSCLE FIBER;

EID: 0035977627     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00178-X     Document Type: Article

References (27)

1. Comparison of prevalence, case history and incidence data in assessing the potency of risk factors in coronary heart disease
2. Risk factors for ischaemic heart disease: The prospective phase of the British Regional Heart Study
3. Menopausal effects on risk factors for ischaemic heart disease
4. Menopause and the risk of cardiovascular disease. The Framingham study
5. Early menopause and risk of myocardial infarction
6. Plasma lipid and lipoprotein levels in perimenopausal women - Clinical research for 1198 Japanese women
7. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia
8. Efficacy and short-term effect of pravastatin, a potent inhibitor of HMG-CoA reductase, on hypercholesterolemia in climacteric women
9. The long term effect of HMG-CoA reductase inhibitor to the hypercholesterolemia in the climacterium and its endocrinological change
10. Enzymatic determination of total serum cholesterol
11. Quantitative determination of serum triglycerides by the use of enzyme
12. Measurements of total HDL, HDL2, HDL3 by dextran sulfate-MgCl2 precipitation technique in human serum
13. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
14. Hypergonadotropinemia with estradiol secretion in peri- and postmenopausal period
15. Estradiol radioimmunoassay without chromatography: Procedure, validation and normal values
16. New developments in lipid-lowering therapy: The role of inhibitors of HMG-CoA reductase
17. High density lipoprotein as a protective factor against coronary heart disease
18. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
19. Efficacy and long-term adverse effect pattern of lovastatin
20. Epideminology as a guide to clinical decisions
21. Triglycerides - Main lipid risk factor for cardiovascular disease in women?
22. The triglyceride issue: A view from Framingham
23. Lipoprotein predictors of the severity of coronary artery disease in men and women
24. The influence of hormonal replacement therapy on lipid and lipoprotein metabolism
25. Simvastatin versus pravastatin: Efficacy and tolerability in patients with primary hypercholesterolemia
26. Effects of bezafibrate on serum lipid concentrations in hypertriglyceridemic perimenopausal patients and on - With effects on serum remnant like particles (RLP-C) metabolism and endocrinologic changes
27. Endocrine function of the peri- and postmenopausal ovary